公开(公告)号：US11096921B2

公开(公告)日：2021-08-24

申请号：US15160218

申请日：2016-05-20

Applicant: AMOREPACIFIC CORPORATION

Inventor： Byung Gyu Kim ,  Hyun Woo Jeong ,  Su Kyung Kim ,  Si Young Cho ,  Chan Woong Park ,  Dae Bang Seo ,  Wan Gi Kim ,  Sang Jun Lee

IPC: A61K31/34 ,  A61K36/258 ,  A23L33/11 ,  A23L33/105 ,  A23L2/52

Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.

公开(公告)号：US10912809B2

公开(公告)日：2021-02-09

申请号：US16471096

申请日：2017-11-21

Applicant: AMOREPACIFIC CORPORATION

Inventor： Su Kyung Kim ,  Jin Oh Chung ,  Wan Gi Kim ,  Jeong Kee Kim ,  Song Seok Shin ,  Soon Mi Shim ,  Da Yeon Lee ,  Sang Ryun Yim ,  Eun Hye Choi

IPC: A61K36/00 ,  A61K36/82 ,  A23L33/105 ,  A61K31/353 ,  A61K36/25 ,  A61K36/8962

Abstract: The present invention relates to an enhancer for catechin uptake enhancer in enterocytes, wherein, by mixing a green tea extract containing catechin as an active ingredient, a Dendropanax morbifera extract, and an onion extract at a proper ratio, the stability in the digestive organ can be improved and, eventually, the catechin uptake in enterocytes can be enhanced.

公开(公告)号：US09452192B2

公开(公告)日：2016-09-27

申请号：US13722676

申请日：2012-12-20

Applicant: AMOREPACIFIC CORPORATION

Inventor： Su Kyung Kim ,  Hyun Jung Shin ,  Chan Su Rha ,  Seung Hun Kim ,  Bum Jin Lee ,  Young Kyung Kim ,  Dae Bang Seo ,  Wan Gi Kim ,  Jin Oh Chung ,  Sang Jun Lee

IPC: A61K36/82

CPC classification number: A61K36/82

Abstract: Disclosed is a composition for preventing or improving metabolic syndrome, including a tea plant leaf extract, a tea plant flower extract and a tea plant seed extract as active ingredients.

Abstract translation: 本发明提供一种用于预防或改善代谢综合征的组合物，包括茶植物叶提取物，茶植物花提取物和茶植物种子提取物作为活性成分。

公开(公告)号：US10022351B2

公开(公告)日：2018-07-17

申请号：US15160239

申请日：2016-05-20

Applicant: AMOREPACIFIC CORPORATION

Inventor： Byung Gyu Kim ,  Hyun Woo Jeong ,  Su Kyung Kim ,  Si Young Cho ,  Chan Woong Park ,  Dae Bang Seo ,  Wan Gi Kim ,  Sang Jun Lee

IPC: A61K31/34 ,  A23L2/52 ,  A61K36/258 ,  A23L33/11 ,  A23L33/105

Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.

公开(公告)号：US09999611B2

公开(公告)日：2018-06-19

申请号：US15160197

申请日：2016-05-20

Applicant: AMOREPACIFIC CORPORATION

Inventor： Byung Gyu Kim ,  Hyun Woo Jeong ,  Su Kyung Kim ,  Si Young Cho ,  Chan Woong Park ,  Dae Bang Seo ,  Wan Gi Kim ,  Sang Jun Lee

IPC: A61K31/34 ,  A23L2/52 ,  A61K36/258 ,  A23L33/11 ,  A23L33/105

CPC classification number: A61K31/34 ,  A23L2/52 ,  A23L33/105 ,  A23L33/11 ,  A23V2002/00 ,  A61K36/258

Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.

公开(公告)号：US09913823B2

公开(公告)日：2018-03-13

申请号：US14352444

申请日：2012-10-18

Applicant: AMOREPACIFIC CORPORATION

Inventor： Byung Gyu Kim ,  Hyun Woo Jeong ,  Su Kyung Kim ,  Si Young Cho ,  Chan Woong Park ,  Dae Bang Seo ,  Wan Gi Kim ,  Sang Jun Lee

IPC: A61K31/34 ,  A23L1/30 ,  A61K36/258 ,  A23L33/11 ,  A23L2/52 ,  A23L33/105

CPC classification number: A61K31/34 ,  A23L2/52 ,  A23L33/105 ,  A23L33/11 ,  A23V2002/00 ,  A61K36/258

Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.

公开(公告)号：US20140371307A1

公开(公告)日：2014-12-18

申请号：US14352444

申请日：2012-10-18

Applicant: AMOREPACIFIC CORPORATION

Inventor： Byung Gyu Kim ,  Hyun Woo Jeong ,  Su Kyung Kim ,  Si Young Cho ,  Chan Woong Park ,  Dae Bang Seo ,  Wan Gi Kim ,  Sang Jun Lee

IPC: A61K31/34 ,  A23L1/30 ,  A61K36/258

CPC classification number: A61K31/34 ,  A23L2/52 ,  A23L33/105 ,  A23L33/11 ,  A23V2002/00 ,  A61K36/258

Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.

Abstract translation: 本发明涉及式1化合物和SIRT 1活化剂，其包括其衍生物或其药学上可接受的盐作为活性成分。 本发明还涉及包含用于解毒的SIRT1激活剂，用于改善代谢紊乱，用于预防或改善眼部疾病或预防或改善免疫疾病的组合物。